AdventHealth Central and East Florida Media Resources
Have an account question? Check out our help center.
AdventHealth for Children leads nation in pediatric BEAR®️ Implants
Choose the health content that’s right for you, and get it delivered right in your inbox.
This spring, AdventHealth marked significant advancements in patient care with three “firsts” representing a leap forward in treatment of cardiovascular conditions.
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
A new bladder cancer Phase II randomized trial opens in Central Florida. The V940 mRNA immunotherapy injection represents precision medicine at its best, according to Dr. Guru Sonpavde.
“Lidera ConscienteMENTE" is an adaptation of the "Be a Mindleader" initiative, which, since launching a year ago, has connected hundreds of families to counseling services.
With type 1 diabetes on the rise, researchers at AdventHealth are trying to identify undiagnosed type 1 diabetes (T1D) in its early stages, in particular among the state’s underserved and minority...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.